UK markets closed

Aprea Therapeutics, Inc. (APRE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.35+0.07 (+1.33%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
7,627
7,627
16,402
23,896
37,879
Selling general and administrative
8,428
8,428
20,970
13,550
14,932
Total operating expenses
15,472
15,472
37,372
37,446
52,811
Operating income or loss
-15,472
-15,472
-37,372
-37,446
-52,811
Total other income/expenses net
-38.926
-38.926
-75,739
317.402
-890.252
Income before tax
-14,287
-14,287
-112,662
-37,127
-53,479
Income from continuing operations
-14,287
-14,287
-112,662
-37,127
-53,479
Net income
-14,287
-14,287
-112,662
-37,127
-53,479
Net income available to common shareholders
-14,287
-14,287
-112,662
-37,127
-53,479
Basic EPS
12.31
-
-67.99
-34.88
-50.61
Diluted EPS
12.31
-
-67.99
-34.88
-50.61
Basic average shares
3,348
-
1,657
1,064
1,057
Diluted average shares
3,348
-
1,657
1,064
1,057